# Pahr Therapeutics, Inc. — Form D

Pahr Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-18. The offering totals $14.0M, of which $4.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-07-18
- Form: D
- Accession: 0001231919-25-000123
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.0M
- Amount sold: $4.7M
- Remaining: $9.3M
- Investors: 4
- Date of first sale: 2025-02-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-552238

## Issuer

- Name: Pahr Therapeutics, Inc.
- CIK: 0002077159
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116
- Phone: (781) 424-9384

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Neil Buckley | Director | Boston, MA |
| Ken Horne | Director | Boston, MA |
| Andrew Levin | Director | BOSTON, MA |
| Atsushi Usami | Director | Boston, MA |
| Neil Buckley | Executive Officer | Boston, MA |
| Amanda Creedon | Executive Officer | BOSTON, MA |
| Neil Buckley | Promoter | Boston, MA |

## More

- [CIK 2077159 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2077159&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-25-000123.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.